<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
p.textodebalo, li.textodebalo, div.textodebalo
{mso-style-name:textodebalo;
mso-style-priority:99;
margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.textodebalochar
{mso-style-name:textodebalochar;
mso-style-priority:99;
font-family:"Tahoma","sans-serif";}
span.EmailStyle22
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle23
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:navy;}
span.EmailStyle24
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:70.85pt 85.05pt 70.85pt 85.05pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>The reference for this article is: <a href="http://www.ncbi.nlm.nih.gov/pubmed/21532741">http://www.ncbi.nlm.nih.gov/pubmed/21532741</a><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>As it was published in a PLoS journal its free access to all.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Based on our studies and recent ones from Brazil, I do believe that to remove Leish from the canine reservoir, transmission from mom to pup will need to be addressed.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Christy Petersen<o:p></o:p></span></p><p class=MsoNormal><a name="_MailEndCompose"><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></a></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Chang, Kwang-Poo [mailto:KwangPoo.Chang@rosalindfranklin.edu] <br><b>Sent:</b> Wednesday, September 28, 2011 10:20 AM<br><b>To:</b> TECSA - Luiz Ristow; John David<br><b>Cc:</b> leish-l@lineu.icb.usp.br; Petersen, Christine A [V PTH]<br><b>Subject:</b> RE: [Leish-l] RES: testing vaccinated dogs for immunopotentiation<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:navy'>Christine Petersen published an article about transplacental transmission of L infantum in the USA canine leishmaniasis. I just wonder about the implication of this finding in considering vaccination against the disease transmitted this way ?<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:navy'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:navy'>KP<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:navy'><o:p> </o:p></span></p><div><div class=MsoNormal align=center style='text-align:center'><hr size=2 width="100%" align=center></div><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> <a href="mailto:leish-l-bounces@lineu.icb.usp.br">leish-l-bounces@lineu.icb.usp.br</a> <a href="mailto:[mailto:leish-l-bounces@lineu.icb.usp.br]">[mailto:leish-l-bounces@lineu.icb.usp.br]</a> <b>On Behalf Of </b>TECSA - Luiz Ristow<br><b>Sent:</b> Wednesday, September 28, 2011 9:08 AM<br><b>To:</b> 'John David'<br><b>Cc:</b> <a href="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</a><br><b>Subject:</b> [Leish-l] RES: testing vaccinated dogs for immunopotentiation</span><o:p></o:p></p></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Hi !<o:p></o:p></span></p><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>There are these papers about<o:p></o:p></span></p><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>These need a very critical reading to discuss<o:p></o:p></span></p><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>This discussion with all about the matter and these papers is very welcome! (at least for me!)<o:p></o:p></span></p><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Regards for all<o:p></o:p></span></p><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Luiz Ristow<o:p></o:p></span></p><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><div><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><img border=0 width=383 height=152 id="Imagem_x005f_x0020_1" src="cid:image001.gif@01CC7DD0.FD000BD0" alt="assinatura de email dr luiz"><o:p></o:p></span></p></div><p class=MsoNormal><span lang=PT-BR style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b><span lang=PT-BR style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>De:</span></b><span lang=PT-BR style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> <a href="mailto:leish-l-bounces@lineu.icb.usp.br">leish-l-bounces@lineu.icb.usp.br</a> <a href="mailto:[mailto:leish-l-bounces@lineu.icb.usp.br]">[mailto:leish-l-bounces@lineu.icb.usp.br]</a> <b>Em nome de </b>John David<br><b>Enviada em:</b> segunda-feira, 26 de setembro de 2011 18:44<br><b>Para:</b> Dr GR Rajasekariah<br><b>Cc:</b> <a href="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</a>; Carlos Gouvea; hubert mazure; <a href="mailto:smithyman@cellabs.com.au">smithyman@cellabs.com.au</a><br><b>Assunto:</b> Re: [Leish-l] testing vaccinated dogs for immunopotentiation<o:p></o:p></span></p></div></div><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'>I think that for any vaccine developed to protect dogs against VL, but which is also meant to prevent transmission of VL to humans, the developers should show that after the vaccinated dog has been challenged with Leishmania, it does not transmit Leishmania to sand flies.</span><span lang=PT-BR><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR>John R David, M.D.<o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'>Richard Pearson Strong Professor Emeritus</span><span lang=PT-BR><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'>Department of Immunology and Infectious Diseases</span><span lang=PT-BR><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'>Harvard School of Public Health</span><span lang=PT-BR><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'>Professor of Medicine, Harvard Medical School</span><span lang=PT-BR><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'>300 W. 23rd Street, Apt. 13K</span><span lang=PT-BR><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'>New York, NY, 10011</span><span lang=PT-BR><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'>Tel: 212 414 8646</span><span lang=PT-BR><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'>Email: <a href="mailto:jdavid@hsph.harvard.edu">jdavid@hsph.harvard.edu</a></span><span lang=PT-BR><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=PT-BR style='font-family:"Helvetica","sans-serif"'> </span><span lang=PT-BR><o:p></o:p></span></p><div><div><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></div><div><p class=MsoNormal><span lang=PT-BR>On Sep 19, 2011, at 12:04 AM, Dr GR Rajasekariah wrote:<o:p></o:p></span></p></div><p class=MsoNormal style='margin-bottom:12.0pt'><span lang=PT-BR><o:p> </o:p></span></p><div><p class=MsoNormal style='margin-bottom:12.0pt'><span lang=PT-BR>Hello EveryOne,<br>I am responding to the topic on European VL Dog vaccine.<br>It is a great challenge in devising a protective vaccine against visceral leishmaniasis in dogs. This point equally applies the same challenge for human situation.<br>Because Th-2 response is so dominant during VL infection, modulating Th-2 into Th-1 response is a big challenge to immunologists.<br><br>Key points lies in the presentation of appropriate antigen in appropriate dose to stimulate the Th-1 dependent protective immune response.<br>I understand several vaccines are in the market and real efficacy of these vaccines will come out once introduced to field conditions.<br><br>I just wanted to inform you that we have a suitable antibody kit for testing the immunopotentiation in dogs following vaccination of dogs.<br>Our assay is based on the released promastigote antigens.<br>It is a highly sensitive assay.<br>Currently we supply reagents for determination of total IgG antibodies in serum.<br>If any particular group is interested then we are able to provide appropriate reagent for detection of specific IgG2 and other isotype specific antibody detection.<br>Because our antibody detection ELISA is based on the exo-antigens such an ELISA would be of exceptional type for measuring antibody response in vaccinated animals.<br>Highly suitable for diagnosing dogs responded to vaccines.<br><br>Recently I came to know that some of commercial kits were found to be not useful for detecting seroconversion in dogs vaccinated with FML vaccine (Leish-Immune) in Brazil.<br>Because we use released antigens in our kit, any such problems will overcome if they use Canine Leish IgG CELISA (Manufacturer Cellabs Pty Ltd Brookvale NSW Australia email <a href="mailto:sales@cellabs.com.au">sales@cellabs.com.au</a>).<br>If any one is interested to know more about our antibody detection ELISA based on exo-antigens please contact us.<br><br>This is for your kind information.<br><br>Dr GR Rajasekariah<br>Sydney<br>Australia<br><a href="mailto:raj@cellabs.com.au">raj@cellabs.com.au</a><br><br><br><br><br><br><br>----- Original Message ----- From: <<a href="mailto:leish-l-request@lineu.icb.usp.br">leish-l-request@lineu.icb.usp.br</a>><br>To: <<a href="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</a>><br>Sent: Wednesday, August 10, 2011 5:18 PM<br>Subject: Leish-l Digest, Vol 44, Issue 3<br><br><o:p></o:p></span></p><p class=MsoNormal><span lang=PT-BR>Send Leish-l mailing list submissions to<o:p></o:p></span></p><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><a href="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</a><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>To subscribe or unsubscribe via the World Wide Web, visit<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>or, via email, send a message with subject or body 'help' to<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><a href="mailto:leish-l-request@lineu.icb.usp.br">leish-l-request@lineu.icb.usp.br</a><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>You can reach the person managing the list at<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><a href="mailto:leish-l-owner@lineu.icb.usp.br">leish-l-owner@lineu.icb.usp.br</a><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>When replying, please edit your Subject line so it is more specific<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>than "Re: Contents of Leish-l digest..."<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Today's Topics:<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 1. European VL Dog Vaccine - CaniLeish?: (jeffrey shaw)<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 2. Re: FW: Leishmaniasis Pathology Network (Moazzem Hossain)<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 3. Re: FW: Leishmaniasis Pathology Network (Moazzem Hossain)<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>----------------------------------------------------------------------<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Message: 1<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Date: Tue, 9 Aug 2011 15:18:44 +0000<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>From: jeffrey shaw <<a href="mailto:jayusp@hotmail.com">jayusp@hotmail.com</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Subject: [Leish-l] European VL Dog Vaccine - CaniLeish?:<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>To: Leish-L <<a href="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Message-ID: <<a href="mailto:COL101-W1CDD4171D44B715B795E9CB200@phx.gbl">COL101-W1CDD4171D44B715B795E9CB200@phx.gbl</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Content-Type: text/plain; charset="windows-1252"<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>CaniLeish?:<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> The European Commission granted a marketing authorisation valid throughout the European Union, for CaniLeish to Virbac S.A. on 14/03/2011.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> This vaccine, CaniLeish?, will initially be launched in Portugal at the end of the first half of 2011. This will be followed rapidly by launches in other countries in the endemic area: Spain, France, Greece and Italy (not in chronological order). This roll-out takes account of the geographical prevalence of the disease and the time required to build vaccine production up to full capacity. The launch in Northern European countries from where there is a flow of summer visitors to the endemic area will be part of a second phase.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> The basis of this vaccine are excreted proteins plus a saponin adjuvant purified from Quil-A. Its efficacy was determined in a 2 year open field trial.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> The vaccine is given to dogs as three injections, three weeks apart, under the skin. The first injection can be given from six months of age, the second injection is given three weeks later and the third three weeks from the second one. Afterward a single ?booster? should be given every year to maintain protection.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>-------------- next part --------------<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>An HTML attachment was scrubbed...<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>URL: <<a href="http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110809/f2404f5e/attachment-0001.htm">http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110809/f2404f5e/attachment-0001.htm</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>------------------------------<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Message: 2<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Date: Wed, 10 Aug 2011 13:07:17 +0600<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>From: Moazzem Hossain <<a href="mailto:directordcbd@gmail.com">directordcbd@gmail.com</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Subject: Re: [Leish-l] FW: Leishmaniasis Pathology Network<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>To: jeffrey shaw <<a href="mailto:jayusp@hotmail.com">jayusp@hotmail.com</a>>, "Prof. Paul Kaye"<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><<a href="mailto:paul.kaye@york.ac.uk">paul.kaye@york.ac.uk</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Cc: "Prof. Dr. Moazzem Hossain" <<a href="mailto:profdrmoazzemhossain@gmail.com">profdrmoazzemhossain@gmail.com</a>>,<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Leish-L <<a href="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Message-ID:<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><<a href="mailto:CAE-TCmS=i=WaT8cAeOXUJmot=KPvMQSLKar6CTfuUBK9M9tsUw@mail.gmail.com">CAE-TCmS=i=WaT8cAeOXUJmot=KPvMQSLKar6CTfuUBK9M9tsUw@mail.gmail.com</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Content-Type: text/plain; charset=windows-1252<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>10 Aug 2011<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Dear Professor Paul Kaye,<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Thank you for your email. Please find attached our supportive letter<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>of interest for Leishmaniasis Pathology Network.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Looking forward for your kind response.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Best regards.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>-- <o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>*Prof. Dr. Moazzem Hossain *<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Ex - Director Disease Control<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Ministry of Health & Family Welfare<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Government of Bangladesh<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>*Mailing address*:<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Founder Chairman and Project Director<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Institute of Allergy & Clinical Immunology of Bangladesh (IACIB)<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Room 4 - 5 (2nd Floor), Green Super Market, Green Road<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Dhaka -1205, Bangladesh.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Phone:880-2-8115646 (O )<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 880-1715038551(Mobile)<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Email: <a href="mailto:directordcbd@gmail.com">directordcbd@gmail.com</a><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>On 8/9/11, jeffrey shaw <<a href="mailto:jayusp@hotmail.com">jayusp@hotmail.com</a>> wrote:<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Date: Tue, 9 Aug 2011 11:58:52 +0100<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>From: <a href="mailto:paul.kaye@york.ac.uk">paul.kaye@york.ac.uk</a><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Subject: Leishmaniasis Pathology Network<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Dear all,<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Invitation to participate in a global pathology<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> network for<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> research and training in leishmaniasis (LeishPathNet)<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> You may recall the Dormy House meeting in 2008<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> and some of<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> the plans we put forward? Over<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> the past<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> couple years, I have also spoken more to a few of you about one<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> idea that was<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> formulated at Dormy, namely of setting up a digital pathology<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> network. I have<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> also had numerous discussions with the major equipment<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> manufacturers to see if<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> any of them would be supportive of helping us to develop such an<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> initiative. There have<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> been two major<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> develoments recently. First,<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Carl Zeiss<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> is willing to work with us to set up an integrated global digital<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> pathology<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> network (providing a significant financial and technical<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> contribution) and<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> second, the Wellcome Trust is willing to review a pre-proposal to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> fund the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> initiative through their new Biomedical Resources Grant scheme<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>(<a href="http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm">http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm</a>)<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> .<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> I have attached an outline of the project that<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> I had sent to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> the Trust for their initial views, which I think is reasonably<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> self-explanatory.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> They appeared very<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> enthusiastic! The main<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> question now is whether enough of<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> you are still supportive? [ I will also be sending this email to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> others, but please feel free to circulate ]<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> I think the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> project will be<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> challenging, but success could have a real impact on the way we<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> conduct<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> business. It should serve not only as a vehicle to enhance<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> research in<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> leishmaniasis, but the model would be equally applicable across<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> a broad range<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> of diseases and global challenges (with leishmaniasis setting<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> the pace).<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> If we wish to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> proceed, the requirements<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> are that we submit a pre-proposal to the Trust by Oct 18th 2011.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> This pre-proposal is short (4 sections of 350 words) and<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> requires<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> letters of support from the community.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> If you are<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> supportive of the idea that<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> we try to take this forward (and there is plenty of scope for<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> later iteration<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> of the detail), I would be grateful if you could please provide<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> me with a<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> letter of support by September<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 12th<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 2011, indicating whether you would like to be a network<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> partner if the bid<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> is successful. You could<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> also be<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> supportive but not wish to become directly involved at this<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> stage, and such<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> letters are equally valuable. Your letter might also stress the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> added value<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> that the network could provide, its importance for research and<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> training and/or<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> for progressing the translational agenda.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> It would also be an opportunity to indicate whether your<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> group (or<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> institute, if multiple groups) would be interested in bidding to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> be one of the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> initial ?designated laboratories?.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> If there is<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> sufficient support to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> proceed and if subsequently the pre-proposal is successful (we<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> will know on 22nd<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Nov), then I will need a few volunteers to help finalise the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> full proposal,<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> which will be due on Jan 26th 2012.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> A funding decision will be made on May 26th<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 2012.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Best wishes<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> and of course I am happy to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> discuss any points further (though I will be out of the UK from<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Aug 10 ?Sept<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 12)<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Paul<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> --<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Professor Paul Kaye, Ph.D., FRCPath.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Deputy Dean (Research), Hull York Medical School, and<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Director, Centre for Immunology and Infection<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Department of Biology and Hull York Medical School<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>University of York<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Wentworth Way<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>York YO10 5YW<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>United Kingdom<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Tel: +44 (0)1904 328840<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Fax: +44 (0)1904 328844<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Email: <a href="mailto:paul.kaye@york.ac.uk">paul.kaye@york.ac.uk</a> <<a href="mailto:paul.kaye@york.ac.uk">mailto:paul.kaye@york.ac.uk</a>><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Centre Administrator and PA: Elizabeth Greensted<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Tel: 01904 328845<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Email: <a href="mailto:liz.greensted@york.ac.uk">liz.greensted@york.ac.uk</a> <<a href="mailto:liz.greensted@york.ac.uk">mailto:liz.greensted@york.ac.uk</a>><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Centre Email: <a href="mailto:cii@york.ac.uk">cii@york.ac.uk</a> <<a href="mailto:cii@york.ac.uk">mailto:cii@york.ac.uk</a>><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Centre website: <a href="http://www.york.ac.uk/cii">http://www.york.ac.uk/cii</a><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Times Higher Education University of the Year 2010<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Email disclaimer: <a href="http://www.york.ac.uk/docs/disclaimer/email.htm">http://www.york.ac.uk/docs/disclaimer/email.htm</a><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>------------------------------<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Message: 3<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Date: Wed, 10 Aug 2011 13:06:47 +0600<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>From: Moazzem Hossain <<a href="mailto:directordcbd@gmail.com">directordcbd@gmail.com</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Subject: Re: [Leish-l] FW: Leishmaniasis Pathology Network<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>To: jeffrey shaw <<a href="mailto:jayusp@hotmail.com">jayusp@hotmail.com</a>>, "Prof. Paul Kaye"<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><<a href="mailto:paul.kaye@york.ac.uk">paul.kaye@york.ac.uk</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Cc: "Prof. Dr. Moazzem Hossain" <<a href="mailto:profdrmoazzemhossain@gmail.com">profdrmoazzemhossain@gmail.com</a>>,<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Leish-L <<a href="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Message-ID:<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><<a href="mailto:CAE-TCmQNUkZdNE5w+Z20bjLC-=vvV9BCP6OLOm9f6RV-BfpXvA@mail.gmail.com">CAE-TCmQNUkZdNE5w+Z20bjLC-=vvV9BCP6OLOm9f6RV-BfpXvA@mail.gmail.com</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Content-Type: text/plain; charset="windows-1252"<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>10 Aug 2011<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Dear Professor Paul Kaye,<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Thank you for your email. Please find attached our supportive letter<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>of interest for Leishmaniasis Pathology Network.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Looking forward for your kind response.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Best regards.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>-- <o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>*Prof. Dr. Moazzem Hossain *<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Ex - Director Disease Control<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Ministry of Health & Family Welfare<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Government of Bangladesh<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>*Mailing address*:<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Founder Chairman and Project Director<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Institute of Allergy & Clinical Immunology of Bangladesh (IACIB)<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Room 4 - 5 (2nd Floor), Green Super Market, Green Road<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Dhaka -1205, Bangladesh.<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Phone:880-2-8115646 (O )<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 880-1715038551(Mobile)<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Email: <a href="mailto:directordcbd@gmail.com">directordcbd@gmail.com</a><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>On 8/9/11, jeffrey shaw <<a href="mailto:jayusp@hotmail.com">jayusp@hotmail.com</a>> wrote:<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Date: Tue, 9 Aug 2011 11:58:52 +0100<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>From: <a href="mailto:paul.kaye@york.ac.uk">paul.kaye@york.ac.uk</a><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Subject: Leishmaniasis Pathology Network<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Dear all,<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Invitation to participate in a global pathology<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> network for<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> research and training in leishmaniasis (LeishPathNet)<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> You may recall the Dormy House meeting in 2008<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> and some of<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> the plans we put forward? Over<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> the past<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> couple years, I have also spoken more to a few of you about one<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> idea that was<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> formulated at Dormy, namely of setting up a digital pathology<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> network. I have<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> also had numerous discussions with the major equipment<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> manufacturers to see if<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> any of them would be supportive of helping us to develop such an<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> initiative. There have<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> been two major<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> develoments recently. First,<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Carl Zeiss<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> is willing to work with us to set up an integrated global digital<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> pathology<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> network (providing a significant financial and technical<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> contribution) and<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> second, the Wellcome Trust is willing to review a pre-proposal to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> fund the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> initiative through their new Biomedical Resources Grant scheme<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>(<a href="http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm">http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm</a>)<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> .<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> I have attached an outline of the project that<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> I had sent to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> the Trust for their initial views, which I think is reasonably<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> self-explanatory.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> They appeared very<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> enthusiastic! The main<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> question now is whether enough of<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> you are still supportive? [ I will also be sending this email to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> others, but please feel free to circulate ]<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> I think the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> project will be<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> challenging, but success could have a real impact on the way we<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> conduct<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> business. It should serve not only as a vehicle to enhance<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> research in<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> leishmaniasis, but the model would be equally applicable across<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> a broad range<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> of diseases and global challenges (with leishmaniasis setting<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> the pace).<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> If we wish to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> proceed, the requirements<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> are that we submit a pre-proposal to the Trust by Oct 18th 2011.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> This pre-proposal is short (4 sections of 350 words) and<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> requires<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> letters of support from the community.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> If you are<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> supportive of the idea that<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> we try to take this forward (and there is plenty of scope for<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> later iteration<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> of the detail), I would be grateful if you could please provide<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> me with a<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> letter of support by September<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 12th<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 2011, indicating whether you would like to be a network<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> partner if the bid<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> is successful. You could<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> also be<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> supportive but not wish to become directly involved at this<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> stage, and such<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> letters are equally valuable. Your letter might also stress the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> added value<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> that the network could provide, its importance for research and<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> training and/or<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> for progressing the translational agenda.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> It would also be an opportunity to indicate whether your<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> group (or<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> institute, if multiple groups) would be interested in bidding to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> be one of the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> initial ?designated laboratories?.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> If there is<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> sufficient support to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> proceed and if subsequently the pre-proposal is successful (we<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> will know on 22nd<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Nov), then I will need a few volunteers to help finalise the<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> full proposal,<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> which will be due on Jan 26th 2012.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> A funding decision will be made on May 26th<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 2012.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Best wishes<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> and of course I am happy to<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> discuss any points further (though I will be out of the UK from<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Aug 10 ?Sept<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> 12)<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> Paul<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR> --<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Professor Paul Kaye, Ph.D., FRCPath.<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Deputy Dean (Research), Hull York Medical School, and<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Director, Centre for Immunology and Infection<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Department of Biology and Hull York Medical School<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>University of York<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Wentworth Way<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>York YO10 5YW<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>United Kingdom<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Tel: +44 (0)1904 328840<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Fax: +44 (0)1904 328844<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Email: <a href="mailto:paul.kaye@york.ac.uk">paul.kaye@york.ac.uk</a> <<a href="mailto:paul.kaye@york.ac.uk">mailto:paul.kaye@york.ac.uk</a>><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Centre Administrator and PA: Elizabeth Greensted<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Tel: 01904 328845<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Email: <a href="mailto:liz.greensted@york.ac.uk">liz.greensted@york.ac.uk</a> <<a href="mailto:liz.greensted@york.ac.uk">mailto:liz.greensted@york.ac.uk</a>><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Centre Email: <a href="mailto:cii@york.ac.uk">cii@york.ac.uk</a> <<a href="mailto:cii@york.ac.uk">mailto:cii@york.ac.uk</a>><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Centre website: <a href="http://www.york.ac.uk/cii">http://www.york.ac.uk/cii</a><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Times Higher Education University of the Year 2010<o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Email disclaimer: <a href="http://www.york.ac.uk/docs/disclaimer/email.htm">http://www.york.ac.uk/docs/disclaimer/email.htm</a><o:p></o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>-------------- next part --------------<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>A non-text attachment was scrubbed...<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Name: Letter Leish UK.doc<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Type: application/msword<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Size: 46080 bytes<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Desc: not available<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>URL: <<a href="http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110810/73f2ae6a/attachment.doc">http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110810/73f2ae6a/attachment.doc</a>><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>------------------------------<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>_______________________________________________<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>Leish-l mailing list<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><a href="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</a><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a><o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>End of Leish-l Digest, Vol 44, Issue 3<o:p></o:p></span></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><span lang=PT-BR>************************************** <o:p></o:p></span></p></blockquote><p class=MsoNormal><span lang=PT-BR><br><br><br><br><br>=======<br>Email scanned by PC Tools - No viruses or spyware found.<br>(Email Guard: 7.0.0.26, Virus/Spyware Database: 6.18330)<br><a href="http://www.pctools.com/">http://www.pctools.com/</a><br>=======<br>_______________________________________________<br>Leish-l mailing list<br><a href="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</a><br><a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a><o:p></o:p></span></p></div></div><p class=MsoNormal><span lang=PT-BR><o:p> </o:p></span></p><div><div><div><p style='margin:0in;margin-bottom:.0001pt'><span lang=PT-BR style='font-size:10.5pt'><o:p> </o:p></span></p></div></div></div></div></body></html>